Grand challenge in microbiome data science: recovering the microbiome as a system
The microbiome has never been only a census of organisms. In its original ecological formula4on, the term described a microbial community embedded in a defined habitat, with its own physicochemical condi4ons and "theatre of ac4vity" [1; 2]. That original framing is useful now because it reminds us that microbes do not act as isolated names on a taxonomic list. They act in place, in communi4es, through metabolism, interac4on, adapta4on, and response to their host or environment.Sequencing transformed the field by making microbial communi4es measurable at scale. For prac4cal reasons, however, much of early microbiome analysis reduced this complexity to taxonomic profiles and rela4ve abundance tables. That reduc4on gave the field its first maps, but it also leR a gap between what microbiomes are and what our standard data structures can easily represent. The grand challenge for microbiome data science is to close that gap: to turn increasingly diverse measurements into knowledge that is reproducible, interpretable, mechanis4c, and ac4onable. In this Grand Challenges ar4cle, we argue that microbiome data science must become the framework that allows microbiomes to be studied as biological systems.To define that space, microbiome data science must be understood not as a single method or data type, but as the framework that connects measurement, computa4on, and interpreta4on across microbial systems. Its scope extends beyond individual samples. It includes compara4ve studies of microbiomes across people, habitats, 4me, loca4ons, interven4ons, and disease states, as well as the residual fingerprints that microbiomes leave in shared environments such as rivers, oceans, drinking-water systems, built environments, and wastewater. The field is therefore not drawing a single map, but the outlines of many microbial con4nents whose boundaries shiR with host state, ecology, technology, and scale. This scope is expanding because measurement is becoming cheaper, faster, and less dependent on cul4va4on. Genomic and mul4-omic methods now make it possible to chart mul4ple microbial habitats within one person, compare niches such as the gut, airway, skin, or wound microbiome, and follow community change under therapy, infec4on, nutri4on, or environmental.Microbiome data can describe ecosystem state and health status, but its larger promise is predic4ve and genera4ve. Historically, many analyses were organized around predefined hypotheses and a limited set of features. As cohorts, longitudinal sampling, and environmental surveillance expand, data science should also discover recurrent states, transi4ons, and candidate mechanisms that generate experimentally testable hypotheses. This changes the role of computa4on from confirming associa4ons to helping decide what should be measured or perturbed next.A central challenge for microbiome data science is to move from func4onal annota4on to func4onal understanding. Marker-gene surveys and early metagenomic projects made microbial communi4es measurable, but they also exposed a persistent problem: knowing which organisms are present does not tell us what the community is doing. The Human Microbiome Project showed this clearly, with taxonomic varia4on across healthy individuals oRen exceeding varia4on in metabolic pathway carriage [3]. Organism-resolved profilers such as HUMAnN2 [4] and bioBakery3 tools [5] connected reads to gene families, pathways, strains, and contribu4ng taxa, while co-abundance gene groups iden4fy ecological and func4onal units that are not fully captured by reference genomes [6; 7].This remains unresolved at several levels. Most microbial genes are s4ll poorly characterized. Pathway presence does not guarantee pathway ac4vity. Community func4on oRen emerges from interac4ons among organisms rather than from any single genome. Metabolic reconstruc4ons such as AGORA2 show how strain-resolved composi4on can be connected to predicted biochemical outputs, including drug biotransforma4on, but this is only part of the future [8]. The next phase must integrate reference-based profiling, reference-light discovery, expression, metabolite data, causa4vely informa4ve experiments, and community-scale modeling [9; 10]. The goal is not simply to annotate more genes. It is to build models that explain how microbial communi4es generate biochemical ac4vity in context.Trustworthy microbiome data begin before sequencing. Sampling strategy, storage, extrac4on, library prepara4on, batch structure, sequencing depth, nega4ve controls, mock communi4es, host metadata, and environmental covariates are part of the experiment, not merely metadata acached aRerward. Microbiome studies oRen seek effects that are small rela4ve to varia4on introduced by geography, diet, medica4on, sampling 4me, hospital prac4ce, laboratory protocol, or contamina4on. Protocol-specific bias and reagent contamina4on can be systema4c and reproducible, which makes them par4cularly dangerous because they can masquerade as biology [21][22][23]. With large datasets, sta4s4cal power does not rescue poor design; it can instead make ar4facts highly significant.The grand challenge is therefore to match design to inference. Cross-sec4onal studies can generate hypotheses, but state transi4ons, resilience, treatment response, and early warning require longitudinal sampling at a cadence compa4ble with microbial dynamics. Measurement models must account for composi4onality, sparsity, absolute load, detec4on limits, and uncertainty from read to feature [24]. Host and environmental variables can confound apparent disease associa4ons and must be modeled explicitly rather than treated as an aRerthought [25]. The decisive ques4on is not whether an associa4on is significant in a table, but whether it survives nega4ve controls, protocol and batch varia4on, appropriate cohort separa4on, and independent valida4on, and whether it generates a laboratory-testable hypothesis that advances biological understanding.A central challenge for microbiome data science is to integrate the different layers through which microbial func4on becomes visible. No single measurement is enough. The metagenome defines the community's gene4c capacity: the organisms, genes, and pathways that are present. Metatranscriptomic and metaproteomic data show which parts of that capacity are being expressed or executed. Metabolites provide the chemical readout of those ac4vi4es, capturing what is produced, consumed, modified, or exchanged. These layers form a kind of func4onal triangle. When they point in the same direc4on, they can strengthen inference. When they disagree, the disagreement itself can be informa4ve, revealing regula4on, inac4ve pathways, host modifica4on, dietary inputs, or cross-feeding between organisms.Longitudinal mul4-omic studies have shown why this macers. Disease-associated microbiomes are not simply altered taxonomic states, but dynamic molecular states involving microbial transcrip4on, metabolites, immune features, diet, and 4me [11]. Yet the field s4ll lacks a common strategy for turning layered measurements into mechanism rather than parallel lists of associated features. Mul4-omic modules and metagenome-informed metaproteomics are important steps because they preserve rela4onships among species, pathways, metabolites, proteins, exposures, and phenotypes [12] [13]. The grand challenge is to use these layers to triangulate func4on: to decide which measurements are needed for a given ques4on, preserve temporal and spa4al structure, and separate causal rela4onships from coincident correla4ons. The goal is not to build bigger matrices. It is to explain how microbiomes change state.Machine learning is becoming central because microbiome data are high-dimensional, sparse, composi4onal, and heterogeneous. It can support diagnosis, risk stra4fica4on, source tracking, outbreak detec4on, phenotype predic4on, feature discovery, and integra4on of sequencing data with clinical or environmental metadata. But predic4on alone is not enough. Cross-study analyses and microbiome classifica4on benchmarks show how strongly apparent performance can depend on cohort structure, feature processing, and valida4on design [26,27]. A model that classifies disease status, hospital site, or wastewater origin accurately may s4ll have learned batch, diet, medica4on, sequencing center, or geography rather than transferable biology.The grand challenge is to make AI robust, interpretable, and biologically constrained. Training and test data should be separated by cohort, 4me, site, or pa4ent whenever those units can leak informa4on; calibra4on and uncertainty should be reported; external validity should be tested; and explanatory features should be resolved at ac4onable levels such as strains, pathways, mobile elements, metabolites, or ecological states. Founda4on models for microbial genomes and sequences are now technically credible [28], but they should be judged against transparent baselines and evaluated for transportability rather than novelty alone. The strongest model will be one that predicts across contexts and helps explain why the system changed. AI should therefore func4on as a hypothesis engine rather than an oracle. For a useful biological, clinical, or surveillance ques4on, a model should expose its dominant drivers, uncertainty, and failure domains, and ideally iden4fy the next measurement or perturba4on that would discriminate between compe4ng explana4ons. Interpretability in this sense is experimental: a model becomes scien4fically valuable when it produces a predic4on or mechanism that can be falsified.Microbiomes are adap4ve systems. They respond to an4bio4cs, diet, inflamma4on, infec4on, pH, oxygen, immune pressure, host 4ssue damage, phages, and nutrient flow. Their behavior is oRen nonlinear: small perturba4ons can be buffered, amplified, or redirected through cross-feeding, compe44on, horizontal gene transfer, or niche replacement. Similar taxonomic configura4ons can support different func4ons, while different communi4es may converge on similar biochemical outputs. Systems biology is therefore needed because it treats the microbiome not as a sta4c list of taxa, but as a network and state space of interac4ng organisms, genes, metabolites, and host or environmental constraints. The next step is to connect observa4on with perturba4on. Longitudinal data can show that a community changed before disease or environmental deteriora4on, but temporal ordering alone does not establish mechanism. Perturba4on-response models are needed to ask whether the change was causal, compensatory, or correlated with another driver. An4bio4c exposure, diet, infec4on, transplanta4on, synthe4c communi4es, bioreactors, organoids, animal models, and natural experiments can all constrain causal models. The aim should not be to assign a causal label from observa4onal machine learning, but to combine temporal structure, mechanis4c priors, and perturba4on evidence to learn state spaces, 4pping points, recovery trajectories, and interven4on targets.A central challenge for microbiome data science is that even well-integrated omics can miss biology if the sample has been averaged at the wrong scale. A stool sample, biopsy, or bulk metagenome collapses organisms across space, cells across physiological states, strains across gene4c backgrounds, and viruses across transient host interac4ons. Spa4al approaches make loca4on a func4onal variable by mapping microbial biogeography together with host transcrip4onal state [14; 15]. Single-cell approaches reveal minority states, stress responses, persisters, and metabolically specialized subpopula4ons that bulk profiles can dilute [16; 17; 18]. Virome, mobilome, and long-read methods add another layer, showing that phages, structural varia4on, recombina4on, methyla4on, and resistance-associated cargo are part of community func4on rather than background noise [19; 20]. The challenge is no longer just to measure more deeply. It is to build models that hold spa4al organiza4on, strain structure, cell state, viral ecology, and mobile gene4c exchange together without flacening away the biology.Microbiome data science cannot mature without stronger benchmarking and standards. Results s4ll depend on database version, marker choice, assembly strategy, classifier, parameter sekng, and preprocessing conven4on. Two pipelines may produce different taxonomic names, gene counts, pathway calls, or resistance profiles from the same reads, and both may look plausible unless tested against defined truth sets. Community-wide benchmarking efforts such as the Cri4cal Assessment of Metagenome Interpreta4on (CAMI) have shown both the value of common datasets and the persistent trade-offs among methods [29,30]. Benchmarking should cover the complete chain from sampling and extrac4on to read processing, assembly, binning, annota4on, normaliza4on, sta4s4cal modeling, and interpreta4on.Standards are not administra4ve overhead. They are how microbiome findings become comparable, reproducible, and reusable. MIxS-style contextual metadata [31], persistent iden4fiers, containerized workflows, versioned reference databases, executable provenance, public benchmark datasets, and the FAIR principles [32] are essen4al for cumula4ve science. For microbiome data, FAIR should be complemented by a prac4cal requirement: analyses should be reanalysis-ready. Raw measurements must remain linked to rich metadata, laboratory protocols, controls, soRware and database versions, parameters, intermediate feature defini4ons, and explicit uncertainty. Reproducibility should include future reproducibility: when a taxonomy, genome catalog, or annota4on database changes, the analysis should be rerunnable and the resul4ng differences should be explainable.A central challenge for microbiome data science is that infrastructure determines what can be known. Microbiome results are shaped by sample context, reference databases, soRware versions, parameters, normaliza4on choices, and intermediate feature construc4on; without that informa4on, the same dataset may be impossible to reinterpret or combine. Shared analysis infrastructures such as MG-RAST demonstrated early that public data become substan4ally more useful when deposi4on is coupled to standardized computa4on and compara4ve analysis [33]. Building on standards for metadata and provenance, the next infrastructure challenge is interoperability at scale: cross-cohort harmoniza4on, privacy-aware or federated analysis, versioned resources, batch-aware modeling, and human scien4fic judgment. Infrastructure should be judged by whether it makes microbiome data easier to compare, reuse, refute, audit, integrate, and interpret, not by whether it adds another isolated database, workflow, or visualiza4on